Description
Introduction
Varilrix injection is a live attenuated vaccine that prevents chickenpox (varicella). It helps the body develop immunity by stimulating the immune system to produce antibodies against the varicella-zoster virus. The vaccine is suitable for individuals aged 12 months and older.
Indications
Varilrix is used to immunize individuals aged 12 months and older against chickenpox. Healthcare providers administer it as a subcutaneous injection, typically in the upper arm.
Dosage and Administration
- For Children Aged 12 Months to 12 Years: Administer a single 0.5 mL dose subcutaneously. Some children may need a second dose.
- For Individuals Aged 13 Years and Older: Administer two doses. Give the second dose 4 to 8 weeks after the first.
You can administer Varilrix simultaneously with other vaccines, provided you inject them at different sites.
Precautions
- Pregnancy and Breastfeeding: Do not use Varilrix during pregnancy. Avoid pregnancy for at least one month after vaccination. Consult your healthcare provider before vaccination if you are pregnant, breastfeeding, or planning to become pregnant.
- Allergic Reactions: Do not use Varilrix if you have a known allergy to any of its components.
- Immunocompromised Individuals: If you have a weakened immune system, consult your healthcare provider before getting vaccinated.
Common Side Effects
Varilrix may cause mild side effects, including redness, swelling, and pain at the injection site. Some individuals may also develop mild to moderate fever or papulo-vesicular eruptions within days or weeks after vaccination.
Storage
Store Varilrix in a refrigerator at temperatures between 2°C and 8°C. Avoid freezing the vaccine and protect it from light. Do not use the vaccine if it is expired.
Conclusion
Varilrix injection provides effective protection against chickenpox in individuals aged 12 months and older. Follow the vaccination schedule and consult your healthcare provider for optimal results.
